The global Anti-Radiation Drug market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Anti-Radiation Drug manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Anti-Radiation Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Radiation Drug. This report contains market size and forecasts of Anti-Radiation Drug in global, including the following market information:
Global Anti-Radiation Drug market revenue, 2020-2025, 2026-2032, ($ millions)
Global Anti-Radiation Drug market sales, 2020-2025, 2026-2032, (K Units)
Global top five Anti-Radiation Drug companies in 2024 (%)
Total Market by Segment:
Global Anti-Radiation Drug market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Anti-Radiation Drug market segment percentages, by Type, 2024 (%)
Adults
Children
Global Anti-Radiation Drug market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Anti-Radiation Drug market segment percentages, by Application, 2024 (%)
Hospital
Clinic
Global Anti-Radiation Drug market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Anti-Radiation Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Radiation Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Anti-Radiation Drug revenues share in global market, 2024 (%)
Key companies Anti-Radiation Drug sales in global market, 2020-2025 (estimated), (K Units)
Key companies Anti-Radiation Drug sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Onconova Therapeutics
Cellerant Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Radiation Drug, market overview.
Chapter 2: Global Anti-Radiation Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Radiation Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Radiation Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Radiation Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Radiation Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Anti-Radiation Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Radiation Drug Overall Market Size
2.1 Global Anti-Radiation Drug Market Size: 2024 VS 2032
2.2 Global Anti-Radiation Drug Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Anti-Radiation Drug Sales: 2020-2032
3 Company Landscape
3.1 Top Anti-Radiation Drug Players in Global Market
3.2 Top Global Anti-Radiation Drug Companies Ranked by Revenue
3.3 Global Anti-Radiation Drug Revenue by Companies
3.4 Global Anti-Radiation Drug Sales by Companies
3.5 Global Anti-Radiation Drug Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Anti-Radiation Drug Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Anti-Radiation Drug Product Type
3.8 Tier 1, Tier 2, and Tier 3 Anti-Radiation Drug Players in Global Market
3.8.1 List of Global Tier 1 Anti-Radiation Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Radiation Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Anti-Radiation Drug Market Size Markets, 2024 & 2032
4.1.2 Adults
4.1.3 Children
4.2 Segment by Type - Global Anti-Radiation Drug Revenue & Forecasts
4.2.1 Segment by Type - Global Anti-Radiation Drug Revenue, 2020-2025
4.2.2 Segment by Type - Global Anti-Radiation Drug Revenue, 2026-2032
4.2.3 Segment by Type - Global Anti-Radiation Drug Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Anti-Radiation Drug Sales & Forecasts
4.3.1 Segment by Type - Global Anti-Radiation Drug Sales, 2020-2025
4.3.2 Segment by Type - Global Anti-Radiation Drug Sales, 2026-2032
4.3.3 Segment by Type - Global Anti-Radiation Drug Sales Market Share, 2020-2032
4.4 Segment by Type - Global Anti-Radiation Drug Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Anti-Radiation Drug Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.2 Segment by Application - Global Anti-Radiation Drug Revenue & Forecasts
5.2.1 Segment by Application - Global Anti-Radiation Drug Revenue, 2020-2025
5.2.2 Segment by Application - Global Anti-Radiation Drug Revenue, 2026-2032
5.2.3 Segment by Application - Global Anti-Radiation Drug Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Anti-Radiation Drug Sales & Forecasts
5.3.1 Segment by Application - Global Anti-Radiation Drug Sales, 2020-2025
5.3.2 Segment by Application - Global Anti-Radiation Drug Sales, 2026-2032
5.3.3 Segment by Application - Global Anti-Radiation Drug Sales Market Share, 2020-2032
5.4 Segment by Application - Global Anti-Radiation Drug Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Anti-Radiation Drug Market Size, 2024 & 2032
6.2 By Region - Global Anti-Radiation Drug Revenue & Forecasts
6.2.1 By Region - Global Anti-Radiation Drug Revenue, 2020-2025
6.2.2 By Region - Global Anti-Radiation Drug Revenue, 2026-2032
6.2.3 By Region - Global Anti-Radiation Drug Revenue Market Share, 2020-2032
6.3 By Region - Global Anti-Radiation Drug Sales & Forecasts
6.3.1 By Region - Global Anti-Radiation Drug Sales, 2020-2025
6.3.2 By Region - Global Anti-Radiation Drug Sales, 2026-2032
6.3.3 By Region - Global Anti-Radiation Drug Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Anti-Radiation Drug Revenue, 2020-2032
6.4.2 By Country - North America Anti-Radiation Drug Sales, 2020-2032
6.4.3 United States Anti-Radiation Drug Market Size, 2020-2032
6.4.4 Canada Anti-Radiation Drug Market Size, 2020-2032
6.4.5 Mexico Anti-Radiation Drug Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Anti-Radiation Drug Revenue, 2020-2032
6.5.2 By Country - Europe Anti-Radiation Drug Sales, 2020-2032
6.5.3 Germany Anti-Radiation Drug Market Size, 2020-2032
6.5.4 France Anti-Radiation Drug Market Size, 2020-2032
6.5.5 U.K. Anti-Radiation Drug Market Size, 2020-2032
6.5.6 Italy Anti-Radiation Drug Market Size, 2020-2032
6.5.7 Russia Anti-Radiation Drug Market Size, 2020-2032
6.5.8 Nordic Countries Anti-Radiation Drug Market Size, 2020-2032
6.5.9 Benelux Anti-Radiation Drug Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Anti-Radiation Drug Revenue, 2020-2032
6.6.2 By Region - Asia Anti-Radiation Drug Sales, 2020-2032
6.6.3 China Anti-Radiation Drug Market Size, 2020-2032
6.6.4 Japan Anti-Radiation Drug Market Size, 2020-2032
6.6.5 South Korea Anti-Radiation Drug Market Size, 2020-2032
6.6.6 Southeast Asia Anti-Radiation Drug Market Size, 2020-2032
6.6.7 India Anti-Radiation Drug Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Anti-Radiation Drug Revenue, 2020-2032
6.7.2 By Country - South America Anti-Radiation Drug Sales, 2020-2032
6.7.3 Brazil Anti-Radiation Drug Market Size, 2020-2032
6.7.4 Argentina Anti-Radiation Drug Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Radiation Drug Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Anti-Radiation Drug Sales, 2020-2032
6.8.3 Turkey Anti-Radiation Drug Market Size, 2020-2032
6.8.4 Israel Anti-Radiation Drug Market Size, 2020-2032
6.8.5 Saudi Arabia Anti-Radiation Drug Market Size, 2020-2032
6.8.6 UAE Anti-Radiation Drug Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Anti-Radiation Drug Major Product Offerings
7.1.4 Amgen Anti-Radiation Drug Sales and Revenue in Global (2020-2025)
7.1.5 Amgen Key News & Latest Developments
7.2 Onconova Therapeutics
7.2.1 Onconova Therapeutics Company Summary
7.2.2 Onconova Therapeutics Business Overview
7.2.3 Onconova Therapeutics Anti-Radiation Drug Major Product Offerings
7.2.4 Onconova Therapeutics Anti-Radiation Drug Sales and Revenue in Global (2020-2025)
7.2.5 Onconova Therapeutics Key News & Latest Developments
7.3 Cellerant Therapeutics
7.3.1 Cellerant Therapeutics Company Summary
7.3.2 Cellerant Therapeutics Business Overview
7.3.3 Cellerant Therapeutics Anti-Radiation Drug Major Product Offerings
7.3.4 Cellerant Therapeutics Anti-Radiation Drug Sales and Revenue in Global (2020-2025)
7.3.5 Cellerant Therapeutics Key News & Latest Developments
8 Global Anti-Radiation Drug Production Capacity, Analysis
8.1 Global Anti-Radiation Drug Production Capacity, 2020-2032
8.2 Anti-Radiation Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Radiation Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Radiation Drug Supply Chain Analysis
10.1 Anti-Radiation Drug Industry Value Chain
10.2 Anti-Radiation Drug Upstream Market
10.3 Anti-Radiation Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Radiation Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Radiation Drug in Global Market
Table 2. Top Anti-Radiation Drug Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Anti-Radiation Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Anti-Radiation Drug Revenue Share by Companies, 2020-2025
Table 5. Global Anti-Radiation Drug Sales by Companies, (K Units), 2020-2025
Table 6. Global Anti-Radiation Drug Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Anti-Radiation Drug Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Anti-Radiation Drug Product Type
Table 9. List of Global Tier 1 Anti-Radiation Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Radiation Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Anti-Radiation Drug Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Anti-Radiation Drug Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Anti-Radiation Drug Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Anti-Radiation Drug Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Anti-Radiation Drug Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Anti-Radiation Drug Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Anti-Radiation Drug Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Anti-Radiation Drug Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Anti-Radiation Drug Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Anti-Radiation Drug Sales, (K Units), 2026-2032
Table 21. By Region � Global Anti-Radiation Drug Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Anti-Radiation Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Anti-Radiation Drug Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Anti-Radiation Drug Sales, (K Units), 2020-2025
Table 25. By Region - Global Anti-Radiation Drug Sales, (K Units), 2026-2032
Table 26. By Country - North America Anti-Radiation Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Anti-Radiation Drug Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Anti-Radiation Drug Sales, (K Units), 2020-2025
Table 29. By Country - North America Anti-Radiation Drug Sales, (K Units), 2026-2032
Table 30. By Country - Europe Anti-Radiation Drug Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Anti-Radiation Drug Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Anti-Radiation Drug Sales, (K Units), 2020-2025
Table 33. By Country - Europe Anti-Radiation Drug Sales, (K Units), 2026-2032
Table 34. By Region - Asia Anti-Radiation Drug Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Anti-Radiation Drug Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Anti-Radiation Drug Sales, (K Units), 2020-2025
Table 37. By Region - Asia Anti-Radiation Drug Sales, (K Units), 2026-2032
Table 38. By Country - South America Anti-Radiation Drug Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Anti-Radiation Drug Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Anti-Radiation Drug Sales, (K Units), 2020-2025
Table 41. By Country - South America Anti-Radiation Drug Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Anti-Radiation Drug Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Anti-Radiation Drug Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Anti-Radiation Drug Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Anti-Radiation Drug Sales, (K Units), 2026-2032
Table 46. Amgen Company Summary
Table 47. Amgen Anti-Radiation Drug Product Offerings
Table 48. Amgen Anti-Radiation Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Amgen Key News & Latest Developments
Table 50. Onconova Therapeutics Company Summary
Table 51. Onconova Therapeutics Anti-Radiation Drug Product Offerings
Table 52. Onconova Therapeutics Anti-Radiation Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Onconova Therapeutics Key News & Latest Developments
Table 54. Cellerant Therapeutics Company Summary
Table 55. Cellerant Therapeutics Anti-Radiation Drug Product Offerings
Table 56. Cellerant Therapeutics Anti-Radiation Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Cellerant Therapeutics Key News & Latest Developments
Table 58. Anti-Radiation Drug Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 59. Global Anti-Radiation Drug Capacity Market Share of Key Manufacturers, 2023-2025
Table 60. Global Anti-Radiation Drug Production by Region, 2020-2025 (K Units)
Table 61. Global Anti-Radiation Drug Production by Region, 2026-2032 (K Units)
Table 62. Anti-Radiation Drug Market Opportunities & Trends in Global Market
Table 63. Anti-Radiation Drug Market Drivers in Global Market
Table 64. Anti-Radiation Drug Market Restraints in Global Market
Table 65. Anti-Radiation Drug Raw Materials
Table 66. Anti-Radiation Drug Raw Materials Suppliers in Global Market
Table 67. Typical Anti-Radiation Drug Downstream
Table 68. Anti-Radiation Drug Downstream Clients in Global Market
Table 69. Anti-Radiation Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Radiation Drug Product Picture
Figure 2. Anti-Radiation Drug Segment by Type in 2024
Figure 3. Anti-Radiation Drug Segment by Application in 2024
Figure 4. Global Anti-Radiation Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Anti-Radiation Drug Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Anti-Radiation Drug Revenue: 2020-2032 (US$, Mn)
Figure 8. Anti-Radiation Drug Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Anti-Radiation Drug Revenue in 2024
Figure 10. Segment by Type � Global Anti-Radiation Drug Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Anti-Radiation Drug Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Anti-Radiation Drug Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Anti-Radiation Drug Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Anti-Radiation Drug Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Anti-Radiation Drug Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Anti-Radiation Drug Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Anti-Radiation Drug Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Anti-Radiation Drug Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Anti-Radiation Drug Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Anti-Radiation Drug Revenue Market Share, 2020-2032
Figure 21. By Region - Global Anti-Radiation Drug Sales Market Share, 2020-2032
Figure 22. By Country - North America Anti-Radiation Drug Revenue Market Share, 2020-2032
Figure 23. By Country - North America Anti-Radiation Drug Sales Market Share, 2020-2032
Figure 24. United States Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Anti-Radiation Drug Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Anti-Radiation Drug Sales Market Share, 2020-2032
Figure 29. Germany Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 30. France Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Anti-Radiation Drug Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Anti-Radiation Drug Sales Market Share, 2020-2032
Figure 38. China Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 42. India Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Anti-Radiation Drug Revenue Market Share, 2020-2032
Figure 44. By Country - South America Anti-Radiation Drug Sales, Market Share, 2020-2032
Figure 45. Brazil Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Anti-Radiation Drug Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Anti-Radiation Drug Sales, Market Share, 2020-2032
Figure 49. Turkey Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Anti-Radiation Drug Revenue, (US$, Mn), 2020-2032
Figure 53. Global Anti-Radiation Drug Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Anti-Radiation Drug by Region, 2024 VS 2032
Figure 55. Anti-Radiation Drug Industry Value Chain
Figure 56. Marketing Channels
